Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	60.21	37.23	85.39	43.99	57.21	87.13
Short-Term Investments	133.16	210.95	284.52	205.24	186.8	299.52
Cash & Short-Term Investments	193.38	248.19	369.91	249.23	244	386.65
Cash Growth	-35.61%	-32.91%	48.42%	2.14%	-36.89%	15.34%
Accounts Receivable	6.79	6.65	8.61	20.32	23.58	23.49
Other Receivables	33.84	32	31	28.72	37.26	13.04
Receivables	40.63	38.65	39.62	49.04	60.83	36.53
Prepaid Expenses	8.86	12.41	13.26	13.45	14.19	13.66
Restricted Cash	-	0.61	-	-	-	-
Total Current Assets	242.86	299.85	422.79	311.71	319.02	436.84
Property, Plant & Equipment	76.68	73.35	34.71	29.75	10.65	15.62
Long-Term Investments	-	-	-	29.29	108.42	32.63
Long-Term Deferred Tax Assets	-	-	-	-	-	0.35
Other Long-Term Assets	3.46	3.45	4.77	4.66	0.7	0.7
Total Assets	322.99	376.65	462.28	375.41	438.79	486.13
Accounts Payable	4.76	8	4.1	6	9.54	5.74
Accrued Expenses	8.31	13.55	18.34	20.94	22.43	14.16
Current Portion of Long-Term Debt	30.68	34.46	35.08	-	-	-
Current Portion of Leases	2.2	1.52	5.28	2.89	4.2	4.26
Total Current Liabilities	45.95	57.54	62.79	29.83	36.17	24.16
Long-Term Debt	126.73	136.13	160.85	1.42	1.51	1.48
Long-Term Leases	56.54	53.94	21.24	22.37	1.13	3.84
Other Long-Term Liabilities	0.24	0.23	0.66	0.45	0.56	1.08
Total Liabilities	229.46	247.84	245.54	54.08	39.36	30.55
Common Stock	0.21	0.21	0.21	0.21	0.2	0.2
Additional Paid-In Capital	461.52	451.34	424.69	398.03	351.03	326.96
Retained Earnings	-367.97	-323.04	-207	-73.18	48.58	127.57
Comprehensive Income & Other	-0.22	0.3	-1.17	-3.72	-0.38	0.84
Shareholders' Equity	93.54	128.81	216.74	321.33	399.43	455.58
Total Liabilities & Equity	322.99	376.65	462.28	375.41	438.79	486.13
Total Debt	216.14	226.06	222.44	26.69	6.84	9.58
Net Cash (Debt)	-22.77	22.13	147.47	251.83	345.58	409.71
Net Cash Growth	-	-85.00%	-41.44%	-27.13%	-15.65%	2.86%
Net Cash Per Share	-1.07	1.05	7.03	12.22	17.13	20.55
Filing Date Shares Outstanding	21.38	21.19	21.06	20.8	20.32	20.08
Total Common Shares Outstanding	21.38	21.19	21.06	20.79	20.24	20.08
Working Capital	196.91	242.32	360	281.89	282.85	412.68
Book Value Per Share	4.38	6.08	10.29	15.46	19.74	22.69
Tangible Book Value	93.54	128.81	216.74	321.33	399.43	455.58
Tangible Book Value Per Share	4.38	6.08	10.29	15.46	19.74	22.69
Machinery	20.33	19.92	19.14	16.79	16.32	15.82
Construction In Progress	1.2	22.75	1.27	2.56	0.02	-
Leasehold Improvements	36.76	13.98	13.8	7.28	7.14	7.09

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q